Original Investigation

Influenza With and Without Oseltamivir Treatment and Neuropsychiatric Events Among Children and Adolescents

JAMA Neurology 10.1001/jamaneurol.2025.1995

August 04, 2025 at 11:00 AM EDT

Read the full article

Is the use of the influenza antiviral oseltamivir associated with serious neuropsychiatric events?In this cohort study, the risk of serious neuropsychiatric events was lowest during periods without influenza. During influenza periods, treatment with oseltamivir was associated with a reduced risk of serious neuropsychiatric events compared with influenza periods without oseltamivir treatment.Oseltamivir use was associated with a reduced risk of serious neuropsychiatric events when used for influenza treatment; findings from this study should inform both caregivers and clinicians on the safety of oseltamivir and its role in preventing influenza-associated complications.

Corresponding Author: James W. Antoon, MD, PhD, MPH, Vanderbilt University Medical Center, 2200 Children’s Way, Nashville, TN 37232 (james.antoon@vumc.org).

Link to the article in your story

We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)

https://jamanetwork.com/journals/jamaneurology/fullarticle/10.1001/jamaneurol.2025.1995?utm_source=for_the_media&utm_medium=referral&utm_campaign=ftm_links&utm_term=080425

Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Need more information? Contact us.

Editor's Picks